Literature DB >> 3391421

Recurrent cervical carcinoma after radical hysterectomy.

D M Larson1, L J Copeland, C A Stringer, D M Gershenson, J M Malone, C L Edwards.   

Abstract

The characteristics of recurrent carcinoma following radical hysterectomy and pelvic lymphadenectomy for cervical carcinoma are not well known. Disease recurrence was noted in 27 of 249 patients (11%) with stage IB cervical carcinoma who were treated with a primary surgical approach between January 1962 and December 1984. Fourteen recurrences (52%) occurred within 1 year of surgery, and 24 (89%) within 2 years. Patients with pelvic node metastases or adenocarcinoma had a significantly higher recurrence rate than did patients with negative nodes (33% vs 8%) or with squamous carcinoma (22% vs 8%). Seventeen patients (63%) had disease recurrence in the pelvis or vulva and 12 of these patients had recurrences within 1 year. Eight patients developed asymptomatic pelvic or vulvar recurrences, and all were diagnosed within 1 year. Ten patients (37%) developed recurrences outside the pelvis and 8 of these experienced recurrence after 1 year. Successful treatment after recurrence was independent of clinical or histopathologic parameters except site of recurrence. Eight of 15 patients (53%) who were treated with irradiation for a recurrence in the pelvis or vulva are free of disease 10 to 126 months (median, 48 months) after recurrence. Since irradiation can aid in salvaging patients with recurrent cervical carcinoma confined to the pelvis following radical surgery, clinical vigilance for this site of recurrence is emphasized.

Entities:  

Mesh:

Year:  1988        PMID: 3391421     DOI: 10.1016/0090-8258(88)90252-1

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  17 in total

1.  Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence.

Authors:  Kazuhiro Kitajima; Kayo Suzuki; Yuji Nakamoto; Yumiko Onishi; Setsu Sakamoto; Michio Senda; Masato Kita; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-13       Impact factor: 9.236

2.  Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.

Authors:  Sang-Won Kim; Mison Chun; Hee-Sug Ryu; Suk-Joon Chang; Tae Wook Kong; Eun Ju Lee; Yong Hee Lee; Young-Taek Oh
Journal:  Strahlenther Onkol       Date:  2017-03-29       Impact factor: 3.621

3.  Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-04-19       Impact factor: 5.315

4.  Pathologic complete remission after preoperative high-dose-rate brachytherapy in patients with operable cervical cancer: preliminary results of a prospective randomized multicenter study.

Authors:  Julia Vízkeleti; Ildikó Vereczkey; Georgina Fröhlich; Szilvia Varga; Katalin Horváth; Tamás Pulay; Imre Pete; Csaba Nemeskéri; Árpád Mayer; Norbert Sipos; Miklós Kásler; Csaba Polgár
Journal:  Pathol Oncol Res       Date:  2014-07-11       Impact factor: 3.201

5.  Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Satoru Morita; Narufumi Suganuma; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-18       Impact factor: 9.236

6.  Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.

Authors:  Erik Mittra; Tarek El-Maghraby; Cesar A Rodriguez; Andrew Quon; I Ross McDougall; Sanjiv S Gambhir; Andrei Iagaru
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

7.  Recurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation.

Authors:  R Manfredi; S Baltieri; A Tognolini; R Graziani; D Smaniotto; N Cellini; L Bonomo
Journal:  Radiol Med       Date:  2008-09-08       Impact factor: 3.469

8.  Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer.

Authors:  Brandon M Barney; Ivy A Petersen; Sean C Dowdy; Jamie N Bakkum-Gamez; Kristi A Klein; Michael G Haddock
Journal:  Radiat Oncol       Date:  2013-04-08       Impact factor: 3.481

9.  Clinical Usefulness of (18)F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor Markers.

Authors:  Ari Chong; Jung-Min Ha; Shin Young Jeong; Ho-Chun Song; Jung Joon Min; Hee-Seung Bom; Ho-Sun Choi
Journal:  Chonnam Med J       Date:  2013-04-25

10.  Risk strata-based therapy and outcome in stage Ib-IIa carcinoma cervix: single-centre ten-year experience.

Authors:  Rajshekar S Kundargi; B Guruprasad; Praveen Shankar Rathod; Pn Shakuntala; K Shobha; Vr Pallavi; K Uma Devi; Ud Bafna
Journal:  Ecancermedicalscience       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.